 | Associate Professor Main Office Address Kennedy Krieger Institute Phone: 443-923-7657 E-mail: Tierney@kennedykrieger.org Administrative Assistant Shirley Eisenhardt |
Education
1984 | BAA | University of Florida |
1989 | M.D. | University of South Florida |
1989-1990 | Transitional Internship | Cook County Hospital |
1990-1992 | General Psychiatry Residency | Johns Hopkins Hospital |
1992-1994 | Child and Adolescent Psychiatry Fellowship | Johns Hopkins Hospital |
Professional Interests
- Genetic and metabolic disorders
- Autism
Click here to learn more about Dr. Tierney's research
Selected Publications
Tierney E, Nwokoro N, Porter FD, Freund LS, Ghuman JK, Kelley RI. Behavior phenotype in the RSH/ Smith-Lemli-Opitz syndrome. American Journal of Medical Genetics. 2001; 98:191-200.
Research Units on Pediatric Psychopharmacology Autism Network (McCracken JT, McGough J, Shah B, Cronin P, Hong D, University of California at Los Angeles; Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, Ohio State University; McDougle CJ, Posey D, Swiezy N, Kohn A, Indiana University; Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Yale University; Tierney E, Ghuman J, Gonzalez NM, Grados M), Kennedy Krieger Institute; Vitiello B, Ritz L, National Institute of Mental Health; Davies M, Columbia University; Robinson J, McMahon D. Nathan Kline Institute (Research Units on Pediatric Psychopharmacology Autism Network), Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine. 2002; 347 (5):314-321.
Belmonte MK, Cook EH, Anderson GM, Rubenstein JLR, Greenough WT, Beckel-Mitchener A, Courchesne E, Boulanger LM, Powell SB, Levitt PR, Perry EK, Jiang YH, DeLorey TM, Tierney E. Autism as a disorder of neural information processing: directions for research and targets for therapy. Molecular Psychiatry. 2004; (7): 646-63.
Research Units on Pediatric Psychopharmacology Autism Network (Aman, M.G., Arnold LE, Ramadan Y, Witwer A, Lindsey R, McDougle CJ, Posey D, Swiezy N, Kohn A, McCracken JT, Shah B, Cronin P, McGough J, Lee L, Scahill L, Martin A, Koenig K, Carroll D, Young C, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados MA. A randomized controlled crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry. 2005; 62 (6): 1266-1274.
Tierney E, Bukelis I, Thompson RE, Ahmed K, Aneja A, Kratz L, Kelley RI.Abnormalities of Cholesterol Metabolism in Autism Spectrum Disorders, American Journal of Medical Genetic, Part B: Neuropsychiatric Genetics.2006; (6):666-8.
Tierney E, AmanMG, StoutDJ, PappasK, Arnold E, Vitiello B, Scahill L, McDougle CJ, McCracken JT, Wheeler C, Martin A, Posey DJ, Shah B. Parent Satisfaction in a Multi-Site Trial of Risperidone in Children with Autism: A Social Validity Study, Parent Satisfaction in a Multi-Site Trial of Risperidone in Children with Autism: A Social Validity Study. Psychopharmacology, e-published 23 November 2006.
Tierney E, Nwokoro N, Porter FD, Freund LS, Ghuman JK, Kelly RI. Behavior phenotype in the RSH/ Smith-Lemli-Opitz syndrome, American Journal of Medical Genetics, 2001, 98:191-200.
Scahill L, McCracken JT, McDougle CJ, Aman MG, Arnold LE, Tierney E, Cronin P, Davies M, Ghuman J, Gonzalez N, Koenig K, Lindsay R, Martin A, McGough J, Posey DJ, Swiezy N, Volkmar F, Ritz L, Vitiello B. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism, Journal of Child and Adolescent Psychopharmacology, 2002, 347 (5) 314-321.
McCracken JT, McGough J, Shah B, Cronin P, Hong D, University of California at Los Angeles; Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, Ohio State University; McDougle CJ, Posey D, Swiezy N, Kohn A, Indiana University; Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Yale University; Tierney E, Ghuman J, Gonzalez NM, Grados M, Kennedy Krieger Institute; Vitiello B, Ritz L, National Institute of Mental Health; Davies M, Columbia University; Robinson J, McMahon D, Nathan Kline Institute (Research Units on Pediatric Psychopharmacology Autism Network), Risperidone in children with autism and serious behavioral problems, New England Journal of Medicine, 2002, 347 (5) 314-321.
Arnold LE., Vitiello B., McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K., Kohn AE, McMahon DJ., Tierney E, Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials, Journal of American Academy of Child and Adolescent Psychiatry, 2003; 42 (12): in press.
